MarketMindUS Markets Closed
AI-assisted · Not financial adviceNot adviceAI-assisted · Not financial advice.
LABT supports PASTEUR Act for antimicrobial resistance
Based on curated news sources (not retail comments)
Over the last 7 days: LABT's innovative Bisphosphocin® platform and support for the PASTEUR Act indicate strong growth potential, though no significant bear risks were identified.